微小RNA在口腔鳞癌中的潜在作用

摘要/Abstract

摘要： 口腔鳞癌是口腔颌面部常见的恶性肿瘤，微小RNA在OSCC的发生发展中起重要作用。本文就微小RNA与OSCC的侵袭转移、诊治及预后进行综述。

Abstract: Oral squamous cell carcinoma (OSCC) is the most common type of malignant tumor. miRNA plays an important role in the development of OSCC. This review will focus on association of miRNA with invasion, metastasis, diagnosis and prognosis of OSCC.

Key words: miRNA, Oral squamous cell carcinoma, possible role

中图分类号:

　R393

陈新周健. 微小RNA在口腔鳞癌中的潜在作用[J]. , 2016, 36(10): 957-960.

参考文献

参考文献：
1. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.J Clin Oncol. 2013, 31(36):4550-9.

2. de Camargo Cancela M, de Souza DL, et al. International incidence of oropharyngeal cancer: a population-based study. Oral Oncol. 2012 ,48(6):484-90.

3. Funk GF, Karnell LH, Robinson RA, et al. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 2002; 24:165-80.

4.Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-54.

5.Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.Nature 2000; 403: 901-6.

6.Pasquinelli AE, Reinhart BJ, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000; 408: 86-89.

7. Salazar C1, Calvopi?a D, Punyadeera C. miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas. Expert Rev Mol Diagn. 2014,14(8):1033-40.

8. Tran N, O'Brien CJ, Clark J, et al. Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck 2010; 32: 1099-111.

9.Wu BH, Xiong XP, Jia J, et al. MicroRNAs: New actors in the oral cancer scene. Oral Oncol 2011; 47: 314-9.

10. Dionne KR1, Warnakulasuriya S, Zain RB,et al. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer. 2015 ,136(3):503-15.

11. Aftab MN, Dinger ME, Perera RJ. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma. Arch Biochem Biophys. 2014,563:60-70.

12. Wu X, Zeng R, Wu S, et al. Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels.Gene. 2015,557(2):195-200.

13. Chiyomaru T1, Seki N2, Inoguchi S,et al. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer. Int J Oncol. 2015,46(2):487-96.

14 .Maimaiti A, Abudoukeremu K, Tie L, et al. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia. Gene. 2015,558(2):271-7.

15. Chan B, Manley J, Lee J,et al. The emerging roles of microRNAs in cancer metabolism. Cancer Lett. 2015 ,356(2 Pt A):301-8.

16. Jackson BL, Grabowska A, Ratan HL. MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers. BMC Cancer. 2014 ,14:930.

17. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.

18. Wu Z, Lu H, Sheng J, et al. Inductive microRNA-21 impairs anti-mycobacterial responses by targeting IL-12 and Bcl-2. FEBS Lett. 2012 ,586(16):2459-67.

19.Li J, Jiang K, Zhao F. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2. Oncol Rep. 2015,33(6):2829-36.

20. Li X, Huang K, Yu J. Inhibition of microRNA-21 upregulates the expression of programmed cell death 4 and phosphatase tensin homologue in the A431 squamous cell carcinoma cell line. Oncol Lett. 2014,(1):203-207.

21. Lv Li, Huang F, Mao H, et al. MicroRNA-21 is overexpressed in renal cell carcinoma. Int J Biol Markers. 2013 ,28(2):201-7.

22. Chen B, Chen X, Wu X, et al. Disruption of microRNA-21 by TALEN leads to diminished cell transformation and increased expression of cell-environment interaction genes. Cancer Lett. 2015 ,356(2 Pt B):506-16.

23.Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors denes cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61.

24. Hedb?ck N, Jensen DH, Specht L, et al. MiR-21 expression in the tumor stroma of oral squamous cell carcinoma: an independent biomarker of disease free survival. PLoS One. 2014,9(4):e95193.

25. Liu X, Wang A, Heidbreder CE, et al. MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS Lett 2010; 584: 4115-20.

26. Wong TS, Ho WK, Chan JY, et al. Mature miR-184 and squamous cell carcinoma of the tongue. ScientificWorldJournal 2009; 9: 130-2

27. Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 2007; 67: 976-83.

28. Wong TS, Liu XB, Wong BY, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008; 14: 2588-92.

29. Chang KW, Liu CJ, Chu TH, et al. Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res 2008; 87: 1063-8.

30. Xia B, Yang S, Liu T, et al. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.Mol Cancer. 2015 ,14:57.

31. Liu X, Jiang L, Wang A, et al. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 2009; 286: 217-22.

32. Casta?eda P, Mu?oz M, García-Rojo G, et al. Association of N-cadherin levels and downstream effectors of Rho GTPases with dendritic spine loss induced by chronic stress in rat hippocampal neurons. J Neurosci Res. 2015 May 23. doi: 10.1002/jnr.23602.

33. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003; 302: 1704-9.

34.Wiklund ED, Gao S, Hulf T, et al. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS one 2011; 6: e27840.

35. Fletcher AM, Heaford AC, Trask DK. Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific miR-205. Transl Oncol 2008; 1: 202-8.
36.Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-8.

37.Kimura S, Naganuma S, Susuki D, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010; 23: 1625-33.

38.Hui AB, Lenarduzzi M, Krushel T, et al. Comprehensive microRNA profiling for head and neck squamous cell carcinomas.Clin Cancer Res 2010; 16: 1129-39.

39. Avissar M, McClean MD, Kelsey KT, et al. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009; 30: 2059-63.

40. Patel RS, Jakymiw A, Yao B, et al. High resolution of microRNA signatures in human whole saliva. Arch Oral Biol 2011; 56: 1506-13.

41. Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009; 15: 5473-7.

42.Yu ZW, Zhong LP, Ji T, et al. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. Oral Oncol 2010; 46: 317-22.

43.Childs G, Fazzari M, Kung G, et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009; 174: 736-45.

44. Christensen BC, Avissar-Whiting M, Ouellet LG, et al. Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 2010; 16: 3713-20.

[1]	陈钱林慧于敬伟李国林. 丹参素在体外条件下对口腔鳞癌细胞 CAL-27抑制作用的研究[J]. , 2019, 39(2): 113-116.
[2]	侯春宁张雪松李国林. 川陈皮素对口腔鳞状细胞癌细胞Cal-27增殖、迁移和侵袭的影响[J]. , 2018, 38(6): 481-484.
[3]	杨宗澄闫广兴王若琳徐欣. microRNA表达调控与口腔鳞状细胞癌[J]. , 2018, 38(5): 476-480.
[4]	张玲敏王海侠侯捷赵严礼毛立民. OPN和MMP-3在口腔鳞癌组织中的表达及意义[J]. , 2018, 38(10): 898-902.
[5]	陈新. 口腔鳞状细胞癌现状[J]. , 2017, 37(5): 462-465.
[6]	李珊珊张瑾. 微小RNA与肿瘤坏死因子-α对成骨分化调控作用研究进展[J]. , 2017, 37(2): 180-183.
[7]	葛奕辰陆文昕李燕. RNAi的作用机制及其在口腔医学领域的研究进展[J]. , 2016, 36(5): 471-474.
[8]	赵天江马洪. 口腔鳞癌患者与健康人外周血清差异表达蛋白的初步研究[J]. , 2016, 36(2): 105-108.
[9]	杜瑞瑞夏现印李晓岑王秀梅. CD105在口腔鳞癌中表达及与病理特征和预后相关性研究[J]. , 2015, 35(4): 266-269.
[10]	杨巧珍王夏夏郭滨孙红英. EMT在口腔鳞癌和扁平苔藓病理机制中的作用[J]. , 2015, 35(4): 296-301.
[11]	刘欣谢鑫. GPNMB对口腔鳞癌细胞增殖、侵袭影响的研究[J]. , 2015, 35(10): 818-821.
[12]	周诺谢庆条黄旋平吴训蒙宁. 术前TPF诱导化疗在中晚期口腔鳞癌治疗中的初步评估[J]. , 2014, 34(10): 734-736.
[13]	邱乐宏；马洪. 口腔鳞癌组织蛋白差异表达的蛋白组学测定[J]. , 2011, 31(8): 453-455.
[14]	张红闯,万延俊,李家锋,贺文鹏,张扬,梁军铭. 口腔癌相关成纤维细胞的特殊体外行为研究[J]. , 2011, 31(2): 84-86.
[15]	姜昱,李怀奇. 口腔鳞癌多西他赛、顺铂和氟尿嘧啶联合用药方案诱导化疗的护理[J]. , 2011, 31(10): 609-611.